Logotype for Vimab Group

Vimab Group (VIMAB) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Vimab Group

Q4 2025 earnings summary

12 Mar, 2026

Executive summary

  • Revenue for Q4 2025 increased by 1.1% year-over-year to 86.6 MSEK, but full-year revenue declined by 3.1% to 313.4 MSEK compared to 2024.

  • Operating loss widened both for Q4 and the full year, with significant negative impact from the divestment of a Hungarian subsidiary.

  • Cash flow from operations improved in Q4 but was negative for the full year, reflecting higher financial costs and increased debt.

Financial highlights

  • Q4 EBITDA was -25.8 MSEK (Q4 2024: -10.2 MSEK); excluding the Hungarian divestment, -11.4 MSEK.

  • Full-year EBITDA was -35.8 MSEK (2024: -13.7 MSEK); excluding the divestment, -21.3 MSEK.

  • Q4 operating result was -48.5 MSEK (Q4 2024: -47.1 MSEK); full-year operating result was -77.7 MSEK (2024: -76.9 MSEK).

  • Net loss for the year was -101.7 MSEK (2024: -84.8 MSEK); EPS was -3.9 SEK (2024: -3.3 SEK).

  • Cash flow from operations for Q4 was 21.7 MSEK (Q4 2024: -0.4 MSEK); for the year, -20.2 MSEK (2024: 1.5 MSEK).

Outlook and guidance

  • VIM Energy Systems is expected to be the fastest-growing segment in 2026, with significant revenue potential from large-scale solar and BESS projects.

  • The company anticipates continued seasonality, with Q1 and Q4 typically weaker due to maintenance cycles.

  • No dividend proposed until stable profitability is achieved.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more